Relay Therapeutics, Inc. Research And Development Expense

Quick Answer

Relay Therapeutics, Inc. reported Research And Development Expense of $99.86 million for the year ending 2020.

  • Relay Therapeutics, Inc. showed an increase of +42.0% in Research And Development Expense from 2019 to 2020.
  • This data is from Relay Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2021.
  • XBRL data for this metric is available from 2019 to 2020 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2020: $99.86 million | Fiscal year 2019: $70.31 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: